Category Archives: Events

Latest From Events

Be the Buzz of BIO at the 2016 BIO CEO and Investor Conference

Buzz of BIO contest, BIO Investor Forum

The nomination period is underway for the Buzz of BIO content at the 2016 CEO & Investor Conference! Each winner will receive a complimentary registration and presentation in the corresponding presentation track, and have the opportunity to impress investors with their company’s latest developments. The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

State Bioscience Groups Discuss Best Practices

CSBA-logo_website

This week the Council of State Bioscience Associations (CSBA) held its annual retreat in Scottsdale, AZ, where over 40 different state-based bioscience advocacy organization gathered to discuss legislative and regulatory best practices that support bioscience industry development. More than 100 invited participants engaged in discussions covering the topics of economic development initiatives, ongoing federal and state legislative industry priorities, and advocacy communications campaigns. BIO’s State Government Relations team would like to extend our gratitude to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO World Congress Update: Call for Proposals Deadline Extended!

BIO World Congress

The 2016 BIO World Congress on Industrial Biotechnology is taking place next April 17-20, 2016 in sunny San Diego, CA. BIO has officially extended the Call for Proposals Deadline to November 20, 2016. So, there is still time to submit an abstract for a panel session, speaker submission, or GreenTech Investor Session! Proposed presentations can cover a range of topics, including: Renewable Chemicals Biobased Products Enzyme development Algae for fuels and bioproducts Specialty Chemicals Synthetic Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Haves and Have Nots in Biotech Venture Capital

US_VC_Funding_2009_2014

Recent data from the BIO Industry Analysis team tells a story of “haves and have-nots” in US biopharma venture capital. Three key findings were discussed Wednesday at the 14th Annual BIO Investor Forum. The first finding from the recent study is that funding of therapeutic companies is strong for late rounds (Series B and above), but weak for Series A. Although total levels of venture funding have been climbing recently, the majority of the increase is from late rounds. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Investor Forum Closes with Record Attendance

BIO_Investor_Forum_RGB_Large

The 14th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all previous attendance and participation records. The energy and buzz around #BIF15 is another sign of the continued strength and resilience of the biotech industry. This year’s forum brought together over 900 registered attendees and 175 presenting companies, facilitating 1700 meetings between investors and senior management for emerging and established biotechnology companies. Scott Whitaker, President of the BIO International Convention and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: